Subscribe

Stanley Frankel, MD

Chief Medical Officer, Cytovia Therapeutics

Articles by Stanley Frankel, MD

Daniel Teper, PharmD, MBA

Selecting Cell Therapy Targets in Cancer

ByStanley Frankel, MD,Daniel Teper, PharmD, MBA

September 21st 2021

The chief executive and medical officers of Cytovia Therapeutics discussed the company's therapeutic targets and cell therapy scaffold.

Stanley R. Frankel, MD

Developing Natural Killer Cell Therapies for Hematologic Malignancies and Solid Tumors

ByDaniel Teper, PharmD, MBA,Stanley Frankel, MD

September 11th 2021

The chief executive and medical officers of Cytovia Therapeutics discussed their natural killer cell therapy technology.

Latest Updated Articles

Trending on CGTlive®

Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years

Patients Treated With AskBio’s Limb-Girdle Muscular Dystrophy Gene Therapy AB-1003 Free of Serious Adverse Events at Up to 52 Weeks

CGTLive®’s Weekly Rewind – October 17, 2025

© 2025 MJH Life Sciences^®

All rights reserved.